Epstein R - Search Results

1

Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.

Vasista A, Stockler M, Martin A, Pavlakis N, Sjoquist K, Goldstein D, Gill S, Jain V, Liu G, Kannourakis G, Kim YH, Nott L, Snow S, Burge M, Harris D, Jonker D, Chua YJ, Epstein R, Bonaventura A, Kiely B. Vasista A, et al. Among authors: epstein r. Oncologist. 2019 Nov;24(11):e1102-e1107. doi: 10.1634/theoncologist.2018-0613. Epub 2019 Apr 1. Oncologist. 2019. PMID: 30936377 Free PMC article. Clinical Trial.

2

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis.

Brungs D, Chen J, Masson P, Epstein RJ. Brungs D, et al. Among authors: epstein rj. Prostate Cancer Prostatic Dis. 2014 Jun;17(2):105-11. doi: 10.1038/pcan.2014.10. Epub 2014 Apr 1. Prostate Cancer Prostatic Dis. 2014. PMID: 24686773 Review.

3

Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced Cancer.

Po-Yen Lin F, Salih OSM, Scott N, Jameson MB, Epstein RJ. Po-Yen Lin F, et al. JCO Clin Cancer Inform. 2022 Oct;6:e2200064. doi: 10.1200/CCI.22.00064. JCO Clin Cancer Inform. 2022. PMID: 36265112

4

A periodic table for cancer.

Epstein RJ. Epstein RJ. Future Oncol. 2015;11(5):785-800. doi: 10.2217/fon.14.315. Future Oncol. 2015. PMID: 25757682 Review.

5

Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma.

Zheng S, Chan H, Epstein RJ, Joseph JE. Zheng S, et al. Among authors: epstein rj. Intern Med J. 2015 Jun;45(6):666-9. doi: 10.1111/imj.12779. Intern Med J. 2015. PMID: 26059878

6

Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach.

Lin FP, Pokorny A, Teng C, Dear R, Epstein RJ. Lin FP, et al. Among authors: epstein rj. BMC Cancer. 2016 Dec 1;16(1):929. doi: 10.1186/s12885-016-2972-z. BMC Cancer. 2016. PMID: 27905893 Free PMC article.

7

Beyond BCG: the approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers.

Young FP, Ende D, Epstein RJ. Young FP, et al. Future Oncol. 2019 Feb;15(4):409-420. doi: 10.2217/fon-2018-0565. Epub 2018 Oct 10. Future Oncol. 2019. PMID: 30301372

8

Can cancer go green? It's up to us.

Epstein RJ, Gu Y, Lin FPY. Epstein RJ, et al. Front Oncol. 2023 Feb 22;13:1074091. doi: 10.3389/fonc.2023.1074091. eCollection 2023. Front Oncol. 2023. PMID: 36910667 Free PMC article. No abstract available.

9

Results of a Prospective Phase 2 Pilot Trial of ¹⁷⁷Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression.

Emmett L, Crumbaker M, Ho B, Willowson K, Eu P, Ratnayake L, Epstein R, Blanksby A, Horvath L, Guminski A, Mahon K, Gedye C, Yin C, Stricker P, Joshua AM. Emmett L, et al. Among authors: epstein r. Clin Genitourin Cancer. 2019 Feb;17(1):15-22. doi: 10.1016/j.clgc.2018.09.014. Epub 2018 Sep 27. Clin Genitourin Cancer. 2019. PMID: 30425003 Clinical Trial.

10

Effective conservative management of locally advanced conjunctival melanoma using initial systemic therapy.

Lami H, Epstein RJ, Cherepanoff S, Conway RM. Lami H, et al. Among authors: epstein rj. Clin Exp Ophthalmol. 2020 Apr;48(3):402-404. doi: 10.1111/ceo.13691. Epub 2019 Dec 6. Clin Exp Ophthalmol. 2020. PMID: 31769923 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,707 results

Search Page

Filters